Dublin, Feb. 12, 2019 (GLOBE NEWSWIRE) -- The "Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761) Companies, Growth Drivers & Challenges" report has been added to ResearchAndMarkets.com's offering.
The Allergic Conjunctivitis Market is expected to be more than a USD 2 Billion market by 2025.
Allergic conjunctivitis is a kind of eye disease in which it affects the eye surfaces and is commonly associated with immune-mediated inflammatory reactions of these structures. The prevalence of the allergic conjunctivitis is found more in summer and spring across the various regions. Pollen, dust, irritants such as cigarette smoke, perfumes etc. are some of the substance that triggers conjunctivitis. Itching is the most typical sign of allergic conjunctivitis, and more than 75 percent of patients report this symptom when seeking treatment. Global allergic conjunctivitis market will grow due to the increasing prevalence of various allergic conjunctivitis, development in medical infrastructure in the developing countries, growing awareness about allergic conjunctivitis among people, increasing aging population and upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. Allergic conjunctivitis is classified mainly in five types: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) and Giant Papillary Conjunctivitis (GPC). China Dominates the Global Allergic Conjunctivitis Patient Population In this report, we have shown a complete insight of country analysis of allergic conjunctivitis patient population. The covered countries are; India, China, Japan, United States, United Kingdom, France, Germany, Italy, and Spain. China dominates the global allergic conjunctivitis patient population numbers. The United States is the leading Country in the Global Allergic Conjunctivitis Market Allergic conjunctivitis market is growing across all parts of the world. Market growth rates vary in the countries covered in the report India, China, Japan, United States, United Kingdom, France, Germany, Italy, and Spain. The United States is a leading country in the global allergic conjunctivitis market due to growing awareness, strong healthcare support system and large patient population. Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Hold Majority of Market in the Global Allergic Conjunctivitis Market On the basis of disease type, global Allergic conjunctivitis market is further segmented into seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) market, vernal keratoconjunctivitis (VKC) market, atopic keratoconjunctivitis (AKC) market, and giant papillary conjunctivitis (GPC) market, globally. Seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) hold the majority of market share in the global allergic conjunctivitis market. Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place In the global allergic conjunctivitis market, allergic conjunctivitis pipeline drugs will play a major role in the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.
Key Topics Covered:
1. Executive Summary 2. Global Allergic Conjunctivitis Market and Patients Analysis 2.1 Allergic Conjunctivitis Market 2.2 Allergic Conjunctivitis Patient Numbers 2.3 Allergic Conjunctivitis Treated Patient Numbers 3. Share Analysis - Global Allergic Conjunctivitis 3.1 Country Market Share 3.2 Patients Population Share 3.3 Treated Patients Population Share 3.4 By Disease Type Share 4. India 4.1 Allergic Conjunctivitis Patient Numbers 4.2 Allergic Conjunctivitis Treated Patient Numbers 4.3 Allergic Conjunctivitis Market 5. China 6. Japan 7. United States 8. United Kingdom 9. France 10. Germany 11. Italy 12. Spain 13. Disease Type - Global Allergic Conjunctivitis Market 13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) 13.2 Vernal Keratoconjunctivitis (VKC) 13.3 Atopic Keratoconjunctivitis (AKC) 13.4 Giant Papillary Conjunctivitis (GPC) 14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs 14.1 Zerviate 14.2 OTX-DP (Dexamethasone Insert) 14.3 ADX-102 14.4 PRT2761 14.5 CVXL-0074 14.6 AK-002 14.7 Bertilimumab 14.8 Reproxalap 14.9 ST-266 14.10 SYL-116011 15. Growth Driver 15.1 Rapid Urbanization and Growth of Particulate Pollution 15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases 16. Challenges 16.1 Diagnostic Challenges 16.2 Undertreated by Patients 17. Santen Pharmaceutical 18. Alcon Inc. (Novartis) 19. Portola Pharmaceuticals Inc. 20. Ocular Therapeutix
For more information about this report visit https://www.researchandmarkets.com/research/2...ergic?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Allergy Drugs , Optical Disorders Drugs
